135 related articles for article (PubMed ID: 15205705)
1. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
Zheng AP; Yu SY; Zhao Y; Wu FL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal Administration.
Li W; Ba H; Huang P; Zheng A; Yang X
Drug Res (Stuttg); 2018 Dec; 68(12):673-679. PubMed ID: 29966151
[TBL] [Abstract][Full Text] [Related]
3. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
Sankar C; Mishra B
Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil loaded chitosan microspheres for chemoembolization.
Denkbaş EB; Seyyal M; Pişkin E
J Microencapsul; 1999; 16(6):741-9. PubMed ID: 10575626
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
Akbuğa J; Bergişadi N
J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
Lim ST; Martin GP; Berry DJ; Brown MB
J Control Release; 2000 May; 66(2-3):281-92. PubMed ID: 10742587
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
9. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
Patil S; Babbar A; Mathur R; Mishra A; Sawant K
J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration.
Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
Curr Drug Deliv; 2012 Mar; 9(2):205-18. PubMed ID: 22023210
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of chitosan microspheres containing doxifluridine.
Yoshino T; Machida Y; Onishi H; Nagai T
Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and evaluation of ranitidine hydrochloride-loaded mucoadhesive microspheres.
Dhankar V; Garg G; Dhamija K; Awasthi R
Polim Med; 2014; 44(2):75-81. PubMed ID: 24967779
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of 5-Fluorouracil loaded chitosan microspheres by a two-step solidification method.
Sun Y; Gu L; Gao Y; Gao F
Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):891-5. PubMed ID: 20606332
[TBL] [Abstract][Full Text] [Related]
16. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
Sankar C; Rani M; Srivastava AK; Mishra B
Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
[TBL] [Abstract][Full Text] [Related]
17. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
Lim LY; Wan LS
J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
[TBL] [Abstract][Full Text] [Related]
18. The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration.
Sun Y; Cui F; Shi K; Wang J; Niu M; Ma R
Drug Dev Ind Pharm; 2009 Mar; 35(3):379-86. PubMed ID: 18951272
[TBL] [Abstract][Full Text] [Related]
19. Two-stage optimization process for formulation of chitosan microspheres.
Dubey RR; Parikh RH
AAPS PharmSciTech; 2004 Feb; 5(1):E5. PubMed ID: 15198526
[TBL] [Abstract][Full Text] [Related]
20. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
